Presentation Information

[28-13-pm15S]Development of paclitaxel-based anticancer prodrugs targeting biomarker enzyme activity

○Seiryo Murakami1, Kyohhei Fujita2, Yasuteru Urano1,2 (1. Grad. Sch. Pharm. Sci., Tokyo Univ., 2. Grad. Sch. Med., Tokyo Univ.)